All Insights
Exploring the science, practice, and business of medicine.
Exploring the science, practice, and business of medicine.
Showing 10 out of 13 Insights
In this episode of Science Snapshot, see how Boston Children’s Hospital used OpenAI’s o3 Deep Research model to surface leads in 18 previously unsolved pediatric cases.
In this episode of Science Snapshot, learn how a new once-daily pill called daraxonrasib is nearly doubling median survival for previously treated metastatic pancreatic cancer patients.
In this episode of Science Snapshot, learn how retatrutide, an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, showed 28.3% average weight loss at 80 weeks, surpassing currently approved injectables in separate trials.
In this episode of Science Snapshot, learn how a cluster of severe illnesses aboard the expedition cruise ship MV Hondius was traced to hantavirus.
In this episode of Science Snapshot, learn how amyloid plaques may trap lithium, lowering it in parts of the brain tied to memory, and how a low dose of lithium orotate reduced Alzheimer pathology and improved memory in mouse models.
In this episode of Science Snapshot, learn how a team from Boston Children's Hospital, Broad Clinical Labs, and Roche piloted an ultra-rapid workflow returning whole-genome sequencing results within a single workday for NICU infants.
The field of stem cell medicine is at a defining moment—brimming with potential, but also complicated by hype, misconceptions, and, in some cases, significant risk for patients. For health care professionals, especially clinicians, keeping pace with advances is essential.
In this Harvard Macy Institute blog post Quantum Thinking is discussed.
Management has moved from broadly applied therapies to more tailored, patient-specific treatments, greatly improving outcomes.
The latest wearable medical devices are transforming clinical research processes and outcomes by enabling clinicians to collect a wealth of data remotely. Such advances are saving time, saving money, and increasing access to clinical trials for a much broader group of people than before.